The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
出版年份 2020 全文链接
标题
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
作者
关键词
-
出版物
Drug Design Development and Therapy
Volume Volume 14, Issue -, Pages 5515-5520
出版商
Informa UK Limited
发表日期
2020-12-15
DOI
10.2147/dddt.s274307
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Factors associated with weight gain in people treated with dolutegravir
- (2020) Lucia Taramasso et al. Open Forum Infectious Diseases
- Inhibition of the mitochondrial complex-1 protects against carbon tetrachloride-induced acute liver injury
- (2019) Hu Hua et al. BIOMEDICINE & PHARMACOTHERAPY
- Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease
- (2019) Jin Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting
- (2019) Kai Juhani Kauppinen et al. AIDS PATIENT CARE AND STDS
- Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
- (2019) Paul E Sax et al. CLINICAL INFECTIOUS DISEASES
- 96 weeks treatment of tenofovir alafenamide vs . tenofovir disoproxil fumarate for hepatitis B virus infection
- (2018) Kosh Agarwal et al. JOURNAL OF HEPATOLOGY
- Brief Report
- (2017) François Raffi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
- (2016) Virginia A. Fonner et al. AIDS
- Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines
- (2016) Ricardo Moure et al. ANTIVIRAL RESEARCH
- Brief Report
- (2016) David Wohl et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients
- (2016) Roberta Gagliardini et al. JOURNAL OF CHEMOTHERAPY
- Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
- (2016) Helen Kovari et al. Open Forum Infectious Diseases
- Implications of Efficient Hepatic Delivery by Tenofovir Alafenamide (GS-7340) for Hepatitis B Virus Therapy
- (2015) Eisuke Murakami et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy
- (2015) Anthony Mills et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial
- (2015) Justin Mandala et al. BMC Pharmacology & Toxicology
- SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen
- (2013) R. Campo et al. CLINICAL INFECTIOUS DISEASES
- Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
- (2010) Nina Friis-Møller et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now